Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b)

Blood

Volumn 101, Issue 12, 2003, Pages 5021-5024

  Kuijpers, Taco W ^a   Maianski, Nikolai A ^b   Tool, Anton T J ^b   Smit, G Peter A ^b   Rake, Jan Peter ^b   Roos, Dirk ^b   Visser, Gepke ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; GRANULOCYTE COLONY STIMULATING FACTOR; LIPOCORTIN 5; PROTEIN BAX; PROTEIN BCL 2;

ADOLESCENT; APOPTOSIS; ARTICLE; BLOOD FLOW; CELL CULTURE; CELL FUNCTION; CELL NUCLEUS; CHILD; CIRCULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1B; GRANULOCYTE; HUMAN; IN VITRO STUDY; MALE; MITOCHONDRION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0038383286     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3128     Document Type: Article

References (25)

1. van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem J. 2002;362:513-532.
2. Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science. 1993;262:580-583.
3. Annabi B, Hiraiwa H, Mansfield BC, et al. The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet. 1998;62:400-405.
4. Veiga-da-Cunha M, Gerin I, Chen YT, et al. The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet. 1999;7:717-723.
5. Veiga-da-Cunha M, Gerin I, Van Schaftingen E. How many forms of glycogen storage disease type I? Eur J Pediatr. 2000;59:314-318.
6. Lin B, Hiraiwa H, Pan CJ, Nordlie RC, Chou JY. Type-1c glycogen storage disease is not caused by mutations in the glucose-6-phosphate transporter gene. Hum Genet. 1999;105:515-517.
7. Visser G, Rake JP, Fernandes J, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr. 2000;137:187-191.
8. Calderwood S, Kilpatrick L, Douglas SD, et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood. 2001;97:376-382.
9. Weston BW, Lin JL, Muenzer J, et al. Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype. Pediatr Res. 2000;48:329-334.
10. Kilpatrick L, Garty BZ, Lundquist KF, et al. Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b. J Clin Invest. 1990;86:196-202.
11. McCawley LJ, Korchak HM, Douglas SD, et al. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. Pediatr Res. 1994;35:84-90.
12. Verhoeven AJ, Visser G, van Zwieten R, Gruszczynska B, Tien Poll-The DW, Smit GP. A convenient diagnostic function test of peripheral blood neutrophils in glycogen storage disease type Ib. Pediatr Res. 1999;45:881-885.
13. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000;407:784-788.
14. Dransfield I, Stocks SC, Haslett C. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood. 1995;85:3264-3273.
15. Jones J, Morgan BP. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunology. 1995;86:651-660.
16. Roos D, De Boer M. Purification and cryopreservation of phagocytes from human blood. Methods Enzym. 1986;132:225-228.
17. Maianski NA, Mul FPJ, van Buul JD, Roos D, Kuijpers TW. Granulocyte colony-stimulating factor (G-CSF) inhibits in neutrophils the mitochondria-dependent activation of caspase-3. Blood. 2002;99:672-679.
18. Yamashita K, Takahashi A, Kobayashi S, et al. Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production. Blood. 1999;93:674-685.
19. Kuijpers TW, Weening RS, Roos D. Laboratory workup for neutrophil dysfunctions: numerical and functional defects. J Immunol Methods. 1999;232:211-229.
20. Watson RW, Rotstein OD, Jimenez M, Parodo J, Marshall JC. Augmented intracellular glutathione inhibits Fas-triggered apoptosis of activated human neutrophils. Blood. 1997;89:4175-4181.
21. Rollet-Labelle E, Grange MJ, Elbim C, Marquetty C, Gougerot-Pocidalo MA, Pasquier C. Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Radic Biol Med. 1998;24:563-572.
22. Leuzzi R, Banhegyi G, Kardon T, et al. Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b. Blood. 2003;101:2381-2387.
23. Ambruso DR, McCabe ER, Anderson D, et al. Infectious and bleeding complications in patients with glycogenosis Ib. Am J Dis Child. 1985;139:691-697.
24. Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781-795.
25. Visser G, Rake JP, Fernandes J, et al. Granulocyte colony-stimulating factor in glycogen storage disease type 1b: results of the European Study on Glycogen Storage Disease type 1. Eur J Pediatr. 2002;161:S83-S87.